Identifying genetic variations that affect disease progression
Official title: A Functional Genomics Platform for the de novo Identification of Disease-relevant Alleles
Funded at Northwestern University at Chicago · NIH-11056142 · Data updated 2026-11-12
This study is looking at how natural differences in our genes can affect the way diseases like HIV progress, and it aims to find out which of these genetic variations might help us create better treatments and understand risks for patients like you.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project start | March 15, 2024 |
| Project end | March 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $180,000 |
| NIH project number | 5R21TR005017-02 |
| Project ID | NIH-11056142 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals with genetic variations that may influence their response to HIV or other infectious diseases.
✕Less likely to help
Patients without any genetic variations relevant to HIV progression may not benefit from this research.
What this research studies
This research focuses on understanding how natural genetic variations in humans can influence the progression of diseases, particularly those related to HIV. By developing a new functional genomics platform, the researchers aim to engineer and analyze these genetic variants to identify those that are relevant to disease outcomes. This approach utilizes advanced gene editing technologies to recreate human genetic variations in a controlled environment, allowing for detailed study of their effects on disease. Patients may benefit from insights gained that could lead to better-targeted treatments and risk assessments.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for diseases like HIV.
How similar studies have gone: Previous research has shown success in identifying genetic variants related to HIV, but this approach aims to expand on those findings in a novel way.
Where this research is happening
-
Northwestern University at Chicago
Chicago, United States Active
Researchers
- Principal investigator: Hultquist, Judd F — Northwestern University at Chicago
- Study coordinator: Hultquist, Judd F
Related research
Other NIH-funded projects on the same topics.
-
High-intensity exercise as a treatment for Parkinson's disease
This study is looking at whether doing high-intensity endurance exercise can help people who have just been diagnosed with Parkinson's disease feel better and slow down their symptoms, especially since current medications don't always do the trick.
-
Software to quickly assess organ dose after radionuclide exposure
This study is creating a helpful software tool that quickly calculates how much radiation your organs absorb after you've taken certain radioactive substances, so you can get better care and treatment based on your individual needs.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for better ways to improve your care and treatment, so you can get more personalized options that work best for you.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for new ways to improve care and treatment for patients, and if you join, you might help test some exciting new methods that could lead to better health for everyone.
-
Investigating innovative approaches to improve health outcomes.
This study is looking for ways to improve care and treatment for patients like you, by trying out new methods that could help manage your health better.
-
Investigating core biological processes
This study is all about exploring important biological processes that affect our health, and it invites patients to help discover new ways to improve care for everyone.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.